Bridgebio Oncology Therapeutics, Inc. (BBOT)
9.09
-0.04
(-0.44%)
USD |
NASDAQ |
Mar 13, 16:00
9.07
-0.02
(-0.22%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics EPS Diluted (Quarterly) : -0.485 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rapport Therapeutics, Inc. | -0.7187 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.80M |
| Total Expenses (Quarterly) | 38.80M |
| Enterprise Value | 304.40M |
| Earnings Yield | -16.45% |
| Normalized Earnings Yield | -16.46 |